scholarly journals Effect of Short Call Admission on Length of Stay and Quality of Care for Acute Decompensated Heart Failure

Circulation ◽  
2008 ◽  
Vol 117 (20) ◽  
pp. 2637-2644 ◽  
Author(s):  
Jennifer L. Schuberth ◽  
Tom A. Elasy ◽  
Javed Butler ◽  
Robert Greevy ◽  
Theodore Speroff ◽  
...  
Keyword(s):  
Heart Failure ◽  
Quality Of Care ◽  
Length Of Stay ◽  
Acute Decompensated Heart Failure ◽  
Decompensated Heart Failure ◽  
Call Admission ◽  
Short Call

scholarly journals Response to Letter Regarding Article, “Effect of Short Call Admissions on Length of Stay and Quality of Care for Acute Decompensated Heart Failure”

Circulation ◽  
2009 ◽  
Vol 119 (1) ◽  
Author(s):  
Christianne L. Roumie ◽  
Robert Greevy ◽  
Jennifer L. Schuberth ◽  
Tom A. Elasy ◽  
Theodore Speroff ◽  
...  
Keyword(s):  
Heart Failure ◽  
Quality Of Care ◽  
Length Of Stay ◽  
Acute Decompensated Heart Failure ◽  
Decompensated Heart Failure ◽  
Short Call

7. Emergency department diuretic dosing in acute decompensated heart failure and its effect on length of stay and re-admission rate

Heart & Lung ◽  
2012 ◽  
Vol 41 (4) ◽  
pp. 414-415 ◽  
Author(s):  
J. Fearon-Clarke ◽  
M. Betty ◽  
B. Vargas ◽  
R. Montesino ◽  
S. Sheris ◽  
...  
Keyword(s):  
Heart Failure ◽  
Emergency Department ◽  
Length Of Stay ◽  
Acute Decompensated Heart Failure ◽  
Admission Rate ◽  
Decompensated Heart Failure

scholarly journals State-of-the-art Structural Interventions in Heart Failure

2019 ◽  
Vol 5 (3) ◽  
pp. 147-154 ◽  
Author(s):  
Jeffrey Park ◽  
Hussam S Suradi
Keyword(s):  
Heart Failure ◽  
Acute Decompensated Heart Failure ◽  
Structural Heart Disease ◽  
Decompensated Heart Failure ◽  
Structural Interventions ◽  
The Past ◽  
Effective Interventions ◽  
The Us ◽  
Multiple Trials

Heart failure (HF) is a leading cause of hospitalisation and healthcare costs worldwide. Acute decompensated heart failure accounts for more than 1 million hospitalisations in the US. Despite advances in the quality of acute and chronic HF disease management, gaps in knowledge about effective interventions to support the transition of care for patients with HF remain. Despite multiple trials of promising therapies, standard care consists of decongestion with IV diuretics and haemodynamic support with vasodilators and inotropes and this has remained largely unchanged during the past 45 years. Newer advances in medical innovations and structural heart disease interventions have now given promise to improved survival, outcomes and quality of life for patients with advanced HF of multiple aetiologies. In this article, we focus on structural interventions in the treatment of patients with HF.

Sign in / Sign up

Export Citation Format

Share Document